EUVIMEDEUVIMED entdecken
Crossref

Characteristics of providers who prescribed only anticholinergic medications for overactive bladder in 2020

Danielle N Carr, Annliz Macharia, Michele R Hacker, William D Winkelman

American Journal of Obstetrics and Gynecology · 2023

DOI: 10.1016/j.ajog.2023.05.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Obstetrics and Gynecology, 2023. Verfasst von Danielle N Carr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Mount Auburn Hospital, Cambridge, MA; Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical…. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: NCATS NIH HHS, Harvard Catalyst, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pharmacologic therapy for overactive bladder typically includes either an anticholinergic or a beta-3 agonist. Based on research that has demonstrated increased risks of cognitive impairment and dementia associated with anticholinergic use, current guidelines support the use of beta-3 agonists rather than anticholinergics in older patients. OBJECTIVE: This study aimed to describe the characteristics of providers prescribing only anticholinergics to treat overactive bladder in patients aged ≥65 years. STUDY DESIGN: The US Centers for Medicare and Medicaid Services publishes data on medications dispensed to Medicare beneficiaries. Data include the National Provider Identifier of the prescriber and the number of pills prescribed and dispensed for any given medication for beneficiaries aged ≥65 years. We obtained each provider's National Provider Identifier, gender, degree, and primary specialty. National Provider Identifiers were linked to an additional Medicare database that includes graduation year. We included providers who prescribed pharmacologic therapy for overactive bladder in 2020 for patients aged ≥65 years. We calculated the percentage of providers who prescribed only anticholinergics (and did not prescribe beta-3 agonists) for overactive bladder and stratified by provider characteristics. Data are reported as adjusted risk ratios. RESULTS: In 2020, 131,605 providers prescribed overactive bladder medications. Of those identified, 110,874 (84.2%) had complete demographic information available. Although only 7% of providers who prescribed medications for overactive bladder were urologists, prescriptions from urologists accounted for 29% of total prescriptions. Among providers prescribing medications for overactive bladder, 73% of female providers prescribed only anticholinergics, whereas 66% of male providers prescribed only anticholinergics (P 40 years of age from graduation prescribed only anticholinergics (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveCognitive DysfunctionUnited StatesHumansAgedMaleFemaleAdultMedicareCholinergic AntagonistsData Collection

Stichwörter der Autor:innen

anticholinergicsbeta-3 agonistcognitive impairmentdementiageriatric medicineoveractive bladderprescribing patternsproviders

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Mount Auburn Hospital, Cambridge, MA; Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Obstetrics, Gynecology, and Reprodu…
  • Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA.
  • Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA.
  • Department of Obstetrics and Gynecology, Mount Auburn Hospital, Cambridge, MA; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA.

Förderung

  • NCATS NIH HHS
  • Harvard Catalyst
  • National Institutes of Health
  • American Urogynecologic Society
  • National Center for Advancing Translational Sciences
  • American Urological Association
  • Harvard University

Zitieren

APA

Carr, D. N., Macharia, A., Hacker, M. R., & Winkelman, W. D. (2023). Characteristics of providers who prescribed only anticholinergic medications for overactive bladder in 2020. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2023.05.024

Vancouver

Carr DN, Macharia A, Hacker MR, Winkelman WD. Characteristics of providers who prescribed only anticholinergic medications for overactive bladder in 2020. American Journal of Obstetrics and Gynecology. 2023. doi:10.1016/j.ajog.2023.05.024

BibTeX
@article{Carr2023,
  author = {Carr, Danielle N and Macharia, Annliz and Hacker, Michele R and Winkelman, William D},
  title = {Characteristics of providers who prescribed only anticholinergic medications for overactive bladder in 2020},
  journal = {American Journal of Obstetrics and Gynecology},
  year = {2023},
  doi = {10.1016/j.ajog.2023.05.024}
}
Kostenlos starten →